Skip to main content

Thought Leadership

Pictured: Paul Perreault, CEO and Managing Director, CSL

Perspectives and Expertise from CSL Leaders
Nov 3, 2022
CSL Head of R&D and Chief Medical Officer Bill Mezzanotte is interviewed in the Australian Financial Review (Subscription Required)
Aug 19, 2022
CSL is taking action by setting 2030 carbon targets, CSL’s Chief Financial Officer says.
May 2, 2022
CSL is building the foundations for decentralised trials to be a core part of its research and development efforts within this decade, speeding up clinical development and opening up trials to more patients. (Subscription Required)
Mar 14, 2022
Lean into the momentum and innovation that the global pandemic inspired, CSL CEO Paul Perreault told attendees of The Economic Times Global Business Summit.
Nov 19, 2021
Leaders in science convened to discuss the most pressing topics in biotech, medicine and policy at the 2021 STAT Summit.
Sep 27, 2021
The CFO of global biotech company CSL, Joy Linton, has reached great heights by embracing ambiguity and saying yes to challenges.
Sep 6, 2021
CSL’s Chief Financial Officer Joy Linton talks to Business Chicks about playing the career long game.
Jul 13, 2021
A condensed version of an address CSL Head of R&D and Chief Medical Officer Bill Mezzanotte gave to the Times Higher Education Health and Wellbeing Summit

Thought Leadership

CSL Behring Podcast: World of Promise

CSL Behring presents the World of Promise podcast series, focused on biotechnology and its promise to transform the lives of people and patients around the world living with serious and rare diseases. Click here to listen.

White Paper: Suffering in Silence

In 2020, CSL Behring commissioned The Economist Intelligence Unit (EIU) to explore the state of rare-disease understanding and management throughout the Asia-Pacific region. Read more here.